Cu(I)Br-mediated preparation of 14C-labeled 3-pyridineacetate derivatives and synthesis of a novel 14C-labeled PDE-IV inhibitor

MEDI 464

Jonathan Z. Ho, Jonathan_ho@merck.com, Department of Drug Metabolism, Merck Research Laboratories, 126 East Lincoln Ave, Rahway, NJ 07065

An efficient protocol for the synthesis of 14C-labeled 3-pyridineacetate (1) and its N-oxide ([14C]2) is described.  Oxidation of this pyridine ([14C]1) to its N-oxide ([14C]2) proceeded in high yield using H2O2 with MeReO3 as a catalyst.  The reaction employs readily available diethyl [2-14C]malonate.  This method has proven to be general in preparation of other pyridineacetate derivatives and their N-oxides which have been typically difficult to prepare by other means.  Our development of the Cu(I)Br-coupling methodology as well as application to the synthesis of a 14C-labeled phosphodiesterase-IV (PDE-IV) inhibitor, [14C]3, are also reported.